4-Hydroxyl-oxoisoaporphine, one small molecule as theranostic agent for simultaneous fluorescence imaging and photodynamic therapy as type II photosensitizer

Photochemical & Photobiological Sciences
2021.0

Abstract

Oxoisoaporphine (OA) is a plant phototoxin isolated from Menispermaceae, however, its weak fluorescence and low water solubility impede it for theranostics. We developed here 4-hydroxyl-oxoisoaporphine (OHOA), which has good singlet oxygen-generating ability (0.06), strong fluorescence (0.72) and improved water solubility. OHOA displays excellent fluorescence for cell imaging and exhibits light-induced cytotoxicity against cancer cell. In vitro model of human cervical carcinoma (HeLa) cell proved that singlet oxygen generated by OHOA triggered photosensitized oxidation reactions and exert toxic effect on tumor cells. The MTT assay using HeLa cells verified the low cytotoxicity of OHOA in the dark and high phototoxicity. Confocal experiment indicates that OHOA mainly distributes in mitochondria and western blotting demonstrated that OHOA induces cell apoptosis via the mitochondrial pathway in the presence of light. Our molecule provides an alternative choice as a theranostic agent against cancer cells which usually are in conflict with each other for most traditional theranostic agents.

Knowledge Graph

Similar Paper

4-Hydroxyl-oxoisoaporphine, one small molecule as theranostic agent for simultaneous fluorescence imaging and photodynamic therapy as type II photosensitizer
Photochemical & Photobiological Sciences 2021.0
One-pot synthesis of oxoaporphines as potent antitumor agents and investigation of their mechanisms of actions
European Journal of Medicinal Chemistry 2022.0
Rational design of β-carboline as an efficient type I/II photosensitizer to enable hypoxia-tolerant chemo-photodynamic therapy
Bioorganic Chemistry 2023.0
Photoactivatable dihydroalkaloids for cancer cell imaging and chemotherapy with high spatiotemporal resolution
Materials Horizons 2020.0
Bis-Arylidene Oxindole–Betulinic Acid Conjugate: A Fluorescent Cancer Cell Detector with Potent Anticancer Activity
ACS Medicinal Chemistry Letters 2015.0
Single-molecule chemiluminescent photosensitizer for a self-activating and tumor-selective photodynamic therapy of cancer
European Journal of Medicinal Chemistry 2019.0
Synthesis of pheophorbide-a conjugates with anticancer drugs as potential cancer diagnostic and therapeutic agents
Bioorganic & Medicinal Chemistry 2011.0
Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy
Bioorganic & Medicinal Chemistry Letters 2019.0
Synthesis and cytotoxic evaluation of several oleanolic acid–uracil/thymine conjugates
MedChemComm 2016.0
Synthesis and evaluation of radiolabeled porphyrin derivatives for cancer diagnoses and their nonradioactive counterparts for photodynamic therapy
RSC Medicinal Chemistry 2022.0